beta-lactams has been researched along with cefazolin in 38 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (cefazolin) | Trials (cefazolin) | Recent Studies (post-2010) (cefazolin) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 3,221 | 525 | 920 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (10.53) | 18.7374 |
1990's | 1 (2.63) | 18.2507 |
2000's | 3 (7.89) | 29.6817 |
2010's | 19 (50.00) | 24.3611 |
2020's | 11 (28.95) | 2.80 |
Authors | Studies |
---|---|
Fukada, S; Kojo, H; Mine, Y; Nishida, M; Nonoyama, S | 1 |
Mitsuhashi, S; Une, T | 1 |
Berry, V; Mizen, L; Woodnutt, G | 1 |
Bennett, DB; Comereski, CR; Williams, PD | 1 |
Fukagawa, Y; Hori, S; Iguchi, H; Ishikura, T; Lein, J; Okamura, K; Sakamoto, M; Shibamoto, N | 1 |
Li, JT; Markus, P; Matesic, D; Park, M | 1 |
Cai, Y; Liang, BB; Pei, F; Wang, R | 1 |
Ahsman, MJ; Mathot, RA; Tibboel, D; Wildschut, ED | 1 |
Hasan, T; Khan, S; Nau, GJ; Sallum, UW; Zheng, X | 1 |
Kees, F; Kees, MG; Kratzer, A; Liebchen, U; Schleibinger, M | 1 |
Iranifam, M; Khabbaz Kharameh, M | 1 |
Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D | 1 |
Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D | 1 |
Kumaraswamy, M; Nizet, V; Olson, J; Pogliano, J; Quach, DT; Rybak, MJ; Sakoulas, G; Singh, NB; Yim, J | 1 |
Gennimata, D; Kiriazopoulos, E; Lombardo, K; Panderi, I; Panteri-Petratou, E; Vonaparti, A; Vourna, P; Zaharaki, S | 1 |
Echevarria, KL; Li, J; Traugott, KA | 1 |
Azar, AE; Callaghan, JJ; Clark, CR; Dowden, AM; Haleem, A; McDanel, DL; Murray-Bainer, S; Noiseux, NO; Willenborg, M | 1 |
Chang, HC; Chen, JC; Chen, PL; Ko, WC; Shih, CH; Su, IH; Sun, YN; Yeh, FH | 1 |
Bruch, R; Chatelle, C; Dincer, C; Kling, A; Rebmann, B; Schumann, S; Urban, G; Weber, W; Wirth, S | 1 |
Hicks, S; McCready, J; Powis, J; Vaisman, A | 1 |
Eumkeb, G; Hobbs, G; Pimchan, T; Srisawat, R; Teethaisong, Y | 1 |
Rybak, MJ; Tran, N | 1 |
Kuruvilla, M; Sexton, M; Thomas, J; Wiley, Z; Wolf, F | 1 |
Begg, EJ; Chin, PKL; Everts, R; Moore, GA; Zhang, M | 1 |
Baldini, LM; Gold, HS; Snyder, GM; Stack, CM; Wright, SB | 1 |
Baldini, G; Ben-Shoshan, M; Carli, F; Matte, G; Moussa, Y; Shuster, J; Tsoukas, C | 1 |
Bayer, AS; Chambers, HF; Chen, L; Ersoy, SC; Fowler, VG; Kreiswirth, B; Li, L; Mediavilla, J; Milan, VT; Otmishi, M; Pak, Y; Proctor, RA; Xiong, YQ | 1 |
Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
Elligsen, M; Lam, PW; Leis, JA; Nathens, AB; Riegert, D; Tarighi, P; Tarshis, J | 1 |
Bonsall, TJ; Miller, CL; Wilhelm, NB | 1 |
Crawford, S; Cuenca, J; Ghosh, N; Newton, P; Reynolds, G | 1 |
Almirante, B; Fernández-Hidalgo, N; González-López, JJ; Larrosa, MN; Pigrau, C; Puig-Asensio, M; Rodríguez-Pardo, D; Suanzes, P; Willekens, R | 1 |
Ahn, JY; Kim, HR; Kim, YC; La, YJ; Oh, DH | 1 |
Dilworth, T; Hernandez, BN; Kesner, J; Mercier, RC; Ryan, K; Thelen, H | 1 |
Cass, A; Davies, J; Davis, JS; Johnson, SA; Legg, A; Meagher, N; Roberts, JA; Roberts, MA; Scheetz, MH; Tong, SYC | 1 |
Edwards, M; Epps, KL; Gonzalez-Estrada, A; Hallo-Carrasco, A; Porter, SB; Stonerock, D | 1 |
Elligsen, M; Eng-Chong, M; Genis, H; Lam, PW; Leis, JA; Li, M; Tarshis, J; Zaltz, A | 1 |
1 review(s) available for beta-lactams and cefazolin
Article | Year |
---|---|
β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Humans; Methicillin; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2017 |
3 trial(s) available for beta-lactams and cefazolin
Article | Year |
---|---|
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Drug-Related Side Effects and Adverse Reactions; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
34 other study(ies) available for beta-lactams and cefazolin
Article | Year |
---|---|
Nocardicin A, a new monocyclic beta-lactam antibiotic V. In vivo evaluation.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbenicillin; Cefazolin; Escherichia coli Infections; Kidney; Liver; Male; Mice; Penicillin Resistance; Proteus Infections; Pseudomonas Infections; Serratia marcescens | 1977 |
Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
Topics: Animals; Bacteria; beta-Lactams; Cefazolin; Cefoxitin; Cephalosporinase; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Stability; Enterobacteriaceae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillinase | 1977 |
Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Biological Availability; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Rats; Rats, Inbred Strains; Serratia Infections | 1992 |
Animal model for evaluating the convulsive liability of beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding, Competitive; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Disease Models, Animal; Drug Combinations; gamma-Aminobutyric Acid; Imipenem; Lactams; Male; Mice; Pentylenetetrazole; Seizures; Thienamycins | 1988 |
PS-6 and PS-7, new beta-lactam antibiotics. In vitro and in vivo evaluation.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefazolin; Male; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Thienamycins | 1980 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
Antibacterial activity of allicin alone and in combination with beta-lactams against Staphylococcus spp. and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoperazone; Disulfides; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Pseudomonas aeruginosa; Staphylococcus; Sulfinic Acids | 2007 |
Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefotaxime; Ceftriaxone; Chromatography, High Pressure Liquid; Humans; Infant, Newborn; Meropenem; Tandem Mass Spectrometry; Thienamycins; Vancomycin | 2009 |
Rapid optical determination of β-lactamase and antibiotic activity.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefazolin; Fluorometry; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions.
Topics: beta-Lactams; Cefazolin; Ceftriaxone; Drug Stability; Ertapenem; Humans; Protein Binding; Ultrafiltration; Vancomycin | 2014 |
Cupric oxide nanoparticles-enhanced chemiluminescence method for measurement of β-lactam antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Copper; Hydrogen Peroxide; Limit of Detection; Luminescent Measurements; Luminol; Microscopy, Electron, Transmission; Nanoparticles; X-Ray Diffraction | 2015 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays | 2016 |
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Ertapenem; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcal Skin Infections | 2016 |
Quantification of three beta-lactam antibiotics in breast milk and human plasma by hydrophilic interaction liquid chromatography/positive-ion electrospray ionization mass spectrometry.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cefuroxime; Chromatography, Liquid; Female; Humans; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Milk, Human; Spectrometry, Mass, Electrospray Ionization | 2017 |
Screening for Beta-Lactam Allergy in Joint Arthroplasty Patients to Improve Surgical Prophylaxis Practice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Arthroplasty; Arthroplasty, Replacement; beta-Lactams; Cefazolin; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Reproducibility of Results; Retrospective Studies; Skin Tests | 2017 |
Dielectrophoresis System for Testing Antimicrobial Susceptibility of Gram-Negative Bacteria to β-Lactam Antibiotics.
Topics: Anti-Infective Agents; beta-Lactams; Cefazolin; Cefepime; Ceftazidime; Doripenem; Electrodes; Electrophoresis; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Microscopy | 2017 |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefuroxime; Drug Monitoring; Female; Humans; Male; Microfluidic Analytical Techniques; Piperacillin; Point-of-Care Testing; Precision Medicine | 2017 |
Optimizing preoperative prophylaxis in patients with reported β-lactam allergy: a novel extension of antimicrobial stewardship.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antimicrobial Stewardship; beta-Lactams; Canada; Cefazolin; Drug Hypersensitivity; Female; Humans; Male; Medical History Taking; Middle Aged; Pharmacists; Prospective Studies; Skin Tests | 2017 |
Boesenbergia rotunda (L.) Mansf. extract potentiates the antibacterial activity of some β-lactams against β-lactam-resistant staphylococci.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cloxacillin; Drug Resistance, Bacterial; Drug Synergism; Humans; Male; Microbial Sensitivity Tests; Plant Extracts; Rats; Staphylococcal Infections; Staphylococcus; Zingiberaceae | 2018 |
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
Topics: beta-Lactams; Cefazolin; Cefepime; Ceftaroline; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin | 2018 |
Perioperative use of cefazolin without preliminary skin testing in patients with reported penicillin allergy.
Topics: Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Drug Hypersensitivity; Humans; Penicillins | 2019 |
Simultaneous Determination of Cefalexin, Cefazolin, Flucloxacillin, and Probenecid by Liquid Chromatography-Tandem Mass Spectrometry for Total and Unbound Concentrations in Human Plasma.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactams; Cefazolin; Cephalexin; Child; Chromatography, High Pressure Liquid; Drug Monitoring; Floxacillin; Humans; Limit of Detection; Middle Aged; Plasma; Probenecid; Tandem Mass Spectrometry; Young Adult | 2018 |
Perioperative antimicrobial prophylaxis and prevention of hepatobiliary surgical site infections.
Topics: Aged; Ampicillin; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Boston; Case-Control Studies; Cefazolin; Digestive System Surgical Procedures; Drug Combinations; Female; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Multivariate Analysis; Perioperative Care; Retrospective Studies; Risk Factors; Sulbactam; Surgical Wound Infection | 2018 |
Reply to: Perioperative use of cefazolin without preliminary skin testing in patients with reported penicillin allergy.
Topics: Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Drug Hypersensitivity; Humans; Penicillins | 2019 |
Scope and Predictive Genetic/Phenotypic Signatures of Bicarbonate (NaHCO
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Phenotype; Predictive Value of Tests; Prevalence; Sodium Bicarbonate; Staphylococcal Infections | 2020 |
Impact of the Allergy Clarification for Cefazolin Evidence-based Prescribing Tool on Receipt of Preferred Perioperative Prophylaxis: An Interrupted Time Series Study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Drug Hypersensitivity; Humans; Interrupted Time Series Analysis; Penicillins; Surgical Wound Infection | 2020 |
The Effect of Beta-lactam Allergy Status on the Rate of Surgical Site Infections: A Retrospective Cohort Study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Cefazolin; Cephalosporins; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Retrospective Studies; Risk Factors; Surgical Wound Infection | 2022 |
Penicillin versus anti-staphylococcal beta-lactams for penicillin-susceptible Staphylococcus aureus blood stream infections: a retrospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Female; Humans; Male; Penicillins; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Empirical use of β-lactam/β-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Cefazolin; Cloxacillin; Cohort Studies; Humans; Lactams; Methicillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Glycopeptides; Humans; Methicillin; Nafcillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2022 |
MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cephalexin; Dicloxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monobactams; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Pharmacist-led improvement in perioperative antibiotic selection for patients with a penicillin allergy label.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Drug Hypersensitivity; Humans; Hypersensitivity; Penicillins; Pharmacists; Pilot Projects; Retrospective Studies; Surgical Wound Infection | 2023 |
Optimizing Cefazolin Prophylaxis in Obstetrical Patients with Reported Beta-Lactam Allergy Undergoing Cesarean Delivery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Drug Hypersensitivity; Female; Humans; Hypersensitivity; Pregnancy | 2023 |